Globus Medical, Inc.
GMED
株式のランク
#1976
Globus Medical, Inc. is a global medical technology company dedicated to... Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
株価
$78.67
時価総額
$10.56B
変化（1日）
-0.49%
変化（1年）
25.40%
国
US
取引 Globus Medical, Inc. (GMED)
カテゴリー
Healthcare
Globus Medical, Inc.（GMED）の収益
Jun 2026 時点の収益 TTM: $3.14B
Globus Medical, Inc. の最新の財務報告によると、現在の収益 (TTM) は $3.14B です。2023 年には $1.57B の収益があり、これは 2022 年の $1.02B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Globus Medical, Inc. の収益履歴（2009 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $3.14B | 24.83% |
| 2024 | $2.52B | 60.62% |
| 2023 | $1.57B | 53.34% |
| 2022 | $1.02B | 6.76% |
| 2021 | $958.10M | 21.43% |
| 2020 | $789.04M | 0.47% |
| 2019 | $785.37M | 10.15% |
| 2018 | $712.97M | 12.11% |
| 2017 | $635.98M | 12.76% |
| 2016 | $563.99M | 3.53% |
| 2015 | $544.75M | 14.84% |
| 2014 | $474.37M | 9.19% |
| 2013 | $434.46M | 12.56% |
| 2012 | $385.99M | 16.45% |
| 2011 | $331.48M | 15.02% |
| 2010 | $288.20M | 13.31% |
| 2009 | $254.34M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.59B | 1,381.29% |
US
|
|
| $35.48B | 1,028.30% |
IE
|
|
| $25.84B | 721.55% |
US
|
|
| $21.00B | 567.62% |
US
|
|
| - | - |
DE
|
